Back to results
US 2011/0257215 A1Published application
Novel co-crystal of tiotropium bromide
AssigneeBoehringer Ingelheim Pharma GMBH & CO.KG
InventorsStephen Watt, Alexander R. Eberlin
Life of this patent
Estimating the term…
Abstract
The invention relates to a new crystalline form of tiotropium bromide, processes for preparing it and its use for preparing a pharmaceutical composition for the treatment of respiratory complaints, particularly for the treatment of COPD (chronic obstructive pulmonary disease) and asthma.
Claims9
1) Crystalline form consisting of tiotropium bromide and urea.
Dependencies are inferred from the claim text.